CONCORDBIOPharmaceuticals
Concord Biotech Ltd — Quarterly Results & Earnings
₹1018.40
-2.34%
Profit Growth YoY-33.59%Latest quarter
Sales Growth YoY-20.35%Latest quarter
Sales CAGR 5Y18.56%5 year compound
Profit CAGR 5Y18.55%5 year compound
📋
Quarterly Performance
YoY Profit Growth-33.59%
🔴 Significant decline
YoY Sales Growth-20.35%
🔴 Significant decline
OPM 5Y Average
42.73%Operating profit margin
EPS Growth 5Y
-26.61%Interest Coverage
1342.00Higher = safer debt servicing
ROE
21.27%ROCE
28.25%💡
Growth Analysis
Concord Biotech Ltd reported YoY profit growth of -33.59% and revenue growth of -20.35% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 18.56% and profits at 18.55% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Concord Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.